ArticleEuropean journal of clinical pharmacology2021

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Rafael Dal-RéPubMed ↗Publisher ↗

No numbers read from the abstract.